Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 10:38 PM
Study NCT ID:
NCT00198367
Status:
COMPLETED
Last Update Posted:
2019-05-28
First Post:
2005-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Hospices Civils de Lyon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-01
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-13
First Submit QC Date:
None
Study First Post Date:
2005-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-23
Last Update Post Date:
2019-05-28
Last Update Post Date Type:
ACTUAL